Psychotic disorders

Company Name	Drug Name	Trade Name	Patent Expires	Approval Date	Revenue	Period
Abbott Biotherapeutics	Chlorpromazine	Chlorpromazine		1982-01-01
Accord Healthcare	Clozapine	Clozapine		2015-11-25
Accord Healthcare	Quetiapine	Quetiapine		2016-11-01
Ajanta Pharma	Olanzapine	Olanzapine		2017-05-30
Ajanta Pharma	Fluphenazine	Fluphenazine		2023-01-05
Alembic Pharmaceuticals	Quetiapine	Quetiapine		2014-10-28
Alembic Pharmaceuticals	Chlorpromazine	Chlorpromazine		2023-07-18
Alexza Pharmaceuticals	Loxapine	Adasuve	2022-05-20	2012-12-21
Alkem Laboratories	Olanzapine	Olanzapine		2015-10-20
Alkem Laboratories	Quetiapine	Quetiapine		2013-02-12
Alkermes	Olanzapine, Samidorphan	Lybalvi	2025-11-23	2021-05-28	$210.905 M	Q2/23-Q1/24
Allergan	Chlorpromazine	Chlorpromazine		1982-01-01
	Droperidol	Droperidol		1991-11-27
	Fluphenazine	Fluphenazine		1987-12-18
	Haloperidol	Haloperidol		1988-05-17
	Lorazepam	Lorazepam		1987-03-23
	Loxapine	Loxapine		1988-06-15
	Loxapine	Loxitane Im		1982-01-01
	Perphenazine	Perphenazine		2016-10-17
	Amitriptyline, Perphenazine	Perphenazine Amitriptyline		1986-08-25
	Quetiapine	Quetiapine		2013-02-27
	Thioridazine	Thioridazine		1983-08-23
	THIOTHIXENE	Thiothixene		1987-06-25
	Trifluoperazine	Trifluoperazine		1988-06-23
Almatica Pharma	Lorazepam	Loreev	2034-01-08	2021-08-27

...

Clinical Trials

Historical Success Rate

Phase 1

73%

32/44

Phase 2

72%

64/89

Phase 3

66%

55/83

Approved: 27Overall Success rate: 35%

All Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Company name

Phase 1

Phase 2

Phase 3

Phase 4

Drug Name

...